A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
|Articles|August 30, 2022
- August 2022
- Volume 88
- Issue 8
Pet Peeves: August 2022
Brought to you by The Sassy Pharmacist
Advertisement
Search Party
Patients who ask for a refill and then put the pharmacy on hold to look for the bottle.
Butt Out
Customers who smoke in the drive-through.
No-Shows
Patients who demand a partial fill and do not come to get the completion.
What's Bothering You?
Bossy patients, abandoned prescriptions, drive-through demands? We want to know! Send your pet peeves to cmollison@pharmacytimes.com. We’ll share them here and online.
Articles in this issue
about 4 years ago
Case Studies: August 2022about 4 years ago
OTC Case Studies: Vitamins and Supplementsabout 4 years ago
Dartisla ODT From Edenbridge Pharmaceuticalsabout 4 years ago
Cultural Competence Sets Pharmacy Professionals Apartabout 4 years ago
Foot Care Is Essential for Patients With Diabetesabout 4 years ago
Generic Product News: August 2022about 4 years ago
Knowing Which OTC Drugs Patients Are Taking Is Vitalabout 4 years ago
Illinois Business Partners With Hospital to Reduce Readmissionsabout 4 years ago
Rx Product News: August 2022Advertisement
Related to this article
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Invasive pneumococcal disease may be the first sign of undiagnosed blood cancers and antibody deficiencies in adults, a new study finds.
A new analysis finds a significant weight loss edge for tirzepatide under one estimand but not another; no head-to-head trial exists at these doses.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What the 2025-2030 Dietary Guidelines Mean for Heart Health
2
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
3
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
4
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL
5